The feds claimed the maker of Claritin, in a price war with the producer of the competing drug Allegra, gave concealed discounts to Cigna and PacifiCare Health Systems in the form of "data processing fees, " interest-free loans and "risk share" rebates tied to growth in an insurer's outlays for antihistamine-like drugs.

FORBES: On The Cover/Top Stories